NSCLC Hub Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user viewing treatment options for NSCLC with his wife.
Potential OPDIVO® (nivolumab) user viewing treatment options for NSCLC with his wife.

Your fight against lung
cancer
may start or
continue here

OPDIVO, alone or with YERVOY, is an
FDA-approved immunotherapy option or combination to treat many types of non-small cell lung cancer (NSCLC)

Actor portrayals.

Advanced NSCLC that tests positive for PD-L1

OPDIVO + YERVOY is a treatment option for certain adults with previously untreated advanced NSCLC that tests positive for PD‐L1

Advanced NSCLC

OPDIVO + YERVOY, with chemotherapy, is a treatment option for adults with previously untreated advanced NSCLC

Early-stage NSCLC before surgery

OPDIVO with chemotherapy is a treatment option for adults with early-stage NSCLC before surgery

Previously treated NSCLC

OPDIVO is a treatment option for adults who have had prior treatments for NSCLC

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about infusions, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO